Abstract
INTRODUCTION
HIV/AIDS pandemic continues to be one of the prominent killer diseases in Tanzania. UNAIDS estimated that more than 40million people worldwide were living with HIV/AIDS by the end of 2004.One third of them were young people between the age of 10-24 years old. Sub-Saharan Africa is the most severely a ected region with over 28million people living with HIV/AIDS at the end of 2003. In Tanzania, it has been estimated that more than two million people are living with HIV/AIDS in 2002 [URT 2003] In developed countries the development and the use of ARV drugs has meant an improved quality of people living with HIV/AIDS. This has brought about the dramatic decline in mortality as a result of AIDS. The introduction of highly active Antiretroviral Therapy [HAART] that is combination of at least three di erent ARV drugs has made it a manageable infectious disease. While HAART has made it a manageable disease, the vast majority from Sub Saharan Africa does not yet have access to this treatment because of poor knowledge on ARV and the availability factor [Horn of Africa Journal of AIDS, July, 2004] Only about 440,000 HIV/AIDS individuals in developing countries are receiving ARV drugs to improve the quality of their health. Of almost 30 million Africans living with HIV/AIDS, only 50,000 are currently being treated with ARV drugs. [UNAIDS, 2003] Tanzania initiated the delivery of ARV drugs to Public Health Facilities in October 2004. Prior to that, few Tanzanians [about 2,000] were able to access ARVs. The plan was targeted to cover 400,000 HIV infected Tanzanians on ARV therapy in a period of ve years. About 90 sites were selected to initiate ARV drugs in the rst year, where by the number of patients expected to be on ARVs in their rst year were 44,000. Currently 19,590 patients are on treatment though the sites are still enrolling more patients [.NACP,2005] The patients are detected by blood test after e ective counselling when attending the VCT centres. The general community turn up to VCT is very poor. This may be due to negative community perceptions and poor knowledge on HIV/AIDS and related facts. ARVs used by HIV/AIDS patients have negatively being perceived by the community due to poor knowledge and negative attitudes on it hence turn up on the use has become very poor. Prevention of HIV/AIDS requires a multi-system approach, which combines basic education, social empowerment and implementation of a programme on ARV provision. As a consequence HIV/AIDS has also brought with it new challenges of how to provide care and support unique to those who fall sick and surviving family members.
To mitigate the HIV/AIDS impact on the health system, the government has adopted among other strategies, the promotion of ARV drugs use by patients with AIDS as well as for post exposure prophylaxis. Before prescribing ARV drugs patients must be tested for the presence of HI-Virus antibody and/or antigens, CD4 counts, Full Blood Picture [FBP] , Liver Function Test [LFT] , and counseling to patients as well as the members of the family. The drugs suppress viral replication, preserve immunity function and prolong disease free survival.
The study was aimed at assessing community knowledge and attitude towards ARV drugs used by HIV infected patients among adults.
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METHODOLOGY

Study setting
The study was conducted in Dodoma urban district, which is one of the ve districts of Dodoma region. The study was selected purposely for convenience and priority, as is one of the areas of concern to target on the provision of ARV drugs
Study design
Descriptive cross-sectional study, which employs both qualitative and quantitative methods of data collection and analysis, was done.
Study population
Population of 12years of age and above were targeted because they are the most a ected by HIV as it has been reported by NACP, 2003 that there is increased number of reported cases in the age group 25-34 in females and 30-39 in male. The assumption is since they are most a ected they may have some characteristic knowledge and di erent attitudes towards the use of ARVs. A structured interview schedule was used in data collection. A Swahili questionnaire that contained both open and closed ended questions was used for data collection.
Data management
Quality check was made at the end of the day to ensure all questionnaires were properly lled. All responses were coded, entered in a computer and analyzed. The results shows that majority of respondents (75.6%) get information through the media such as Television, Radio and magazine.1.7%get information from the place of work that means less is discussed in the places of work The results shows that majority of respondents (75.6%) get information through the media such as Television, Radio and magazine.1.7%get information from the place of work that means less is discussed in the places of work Table above shows that most people know that ARVs increases the body immunity and improve the quality of health among PLWHA by 48.5% and 49.5% respectively. Most of them being the age group 12-22 who responded that it increases the body immunity and 56-66 who responded that it improves the quality of health.
RESULTS.
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DMSJ Vol. 14 (Suppl. 1) This study shows that the main source of information about ARVs was Media. Most of those interviewed reported to get information about ARVs and majority were in reproductive age group 12 to 44 years and they have a maximum average of 74%. Therefore the media is a good source of information to reach the target population.
The study also showed that 84% of the interviewed population declared that taking ARVs improves the life of PLWHA. This nding relates with those of the study done in Soweto South Africa which also shows that 80%of interviewed adult population reported that if they were taking ARVs they would not be worried about their families or their friends [Nachega et al 2003] . As it has revealed that more males are accessible to information compared to female. Those respondents who responded that it improves life they responded to the options that it improves life by increasing the body immunity hence improving the quality of life. Only 0.5%of all the respondents respond that ARVs treats HIV/AIDS, this shows that those who have an idea on ARVs they also know how ARVs work. On the other hand those who responds that they will not advice the use of ARVs they give the reasons that, ARVs are very expensive 82.1% hence it could be di cult for them to complete the doses, cause early death 12.8% and only 5. love and grace, for giving me strength and courage that enabled make the rst step, and replenished and sustained my energy thought my school career and during this study.
Needless to say, for many of the errors and patches of ignorance that remain, the ultimate responsibility rests with me
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